Immunity to Campylobacter: its role in risk assessment and epidemiology

A.H. Havelaar, W. van Pelt, C.W. Ang, J.A. Wagenaar, J.P.M. van Putten, U. Gross, D.G. Newell

    Research output: Contribution to journalArticleAcademicpeer-review

    114 Citations (Scopus)


    Acquired immunity is an important factor in the epidemiology of campylobacteriosis in the developing world, apparently limiting symptomatic infection to children of less than two years. However, also in developed countries the highest incidence is observed in children under five years and the majority of Campylobacter infections are asymptomatic, which may be related to the effects of immunity and/or the ingested doses. Not accounting for immunity in epidemiological studies may lead to biased results due to the misclassification of Campylobacter-exposed but apparently healthy persons as unexposed. In risk assessment studies, health risks may be overestimated when immunity is neglected.
    Original languageEnglish
    Pages (from-to)1-22
    JournalCritical Reviews in Microbiology
    Issue number1
    Publication statusPublished - 2009


    • guillain-barre-syndrome
    • intestinal epithelial-cells
    • human-antibody response
    • reactive arthritis patients
    • inflammatory-bowel-disease
    • linked-immunosorbent-assay
    • outer-membrane proteins
    • western-blot-analysis
    • jejuni infection
    • dose-response


    Dive into the research topics of 'Immunity to Campylobacter: its role in risk assessment and epidemiology'. Together they form a unique fingerprint.

    Cite this